Insmed | INSM - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Cytokinetics USD -826.57M 166.94M 2026-03
DBV Technologies USD 168.77M 115.92M 2025-12
Gilead Sciences USD 23.52B 897M 2026-03
Heron Therapeutics USD 9.14M 4.15M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Novartis USD 46.13B 1.8B 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03